This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What Do Canopy Earnings Say About Cannabis ETFs?
by Sanghamitra Saha
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
Are Options Traders Betting on a Big Move in Canopy Growth (CGC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
DexCom's (DXCM) fourth-quarter earnings are likely to reflect top-line growth and rising global awareness of the company's real-time CGM.
Cannabis Therapy to Drive Canopy Growth's (CGC) Q3 Earnings
by Zacks Equity Research
Key acquisitions are expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal third quarter
Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $22.33, marking a +1% move from the previous day.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $23.52 in the latest trading session, marking a -1.67% move from the prior day.
What's in Store for Pot Stocks This Year?
by Nitish Marwah
Increasing tolerance, financial protection, credit availability and legal votes have shaped America's hemp industry lately.
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $24.56 in the latest trading session, marking a +1.82% move from the prior day.
Implied Volatility Surging for Canopy Growth (CGC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
Constellation Brands (STZ) Beats on Q3 Earnings, Ups View
by Zacks Equity Research
Constellation Brands' (STZ) top and bottom lines beat estimates in third-quarter fiscal 2020 on strength in the beer business and improved margins. It raises earnings and cash flow guidance.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $19.80, marking a -1.39% move from the previous day.
Canopy Growth Corporation (CGC) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $19.20, marking a -0.1% move from the previous day.
What's Ahead for Marijuana ETFs After a Dismal Show in 2019?
by Sanghamitra Saha
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
5 Cheap Stocks Trading Under $20 to Buy for 2020
by Benjamin Rains
Let's dive into five strong stocks currently trading for under $20 per share we found with our Zacks Stock Screener that investors might want to buy for 2020...
Ride the Cannabis Wave With These 3 Stocks
by Urmimala Biswas
Here we discuss three best stocks in the emerging cannabis space.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $20.02, moving -0.25% from the previous trading session.
Implied Volatility Surging for Canopy Growth (CGC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
Company News for Dec 10, 2019
by Zacks Equity Research
Companies in the news are: ARQL, THOR, CGC, FATE
Marijuana ETFs Bounce Back: Can the Rally Last?
by Sanghamitra Saha
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
Understanding Options During a Marijuana Stocks Rally
by David Borun
With pot stocks getting a boost from legalization efforts, understanding options is key to making the best value decision
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Have marijuana Stocks Finally Bottomed out?
by David Borun
Two new piece of legislation in Congress promise to lift this slumping industry
Canopy Growth (CGC) Q2 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Canopy Growth (CGC) reports mixed fiscal second-quarter results on strength in its core segments.